Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Cardiovascular Drug Development.

Publication ,  Journal Article
Stockbridge, N; Miller, K; Amur, S; Hillebrenner, M; Zuckerman, B; Fiuzat, M; Califf, RM
Published in: Jacc Heart Fail
January 2017

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Jacc Heart Fail

DOI

EISSN

2213-1787

Publication Date

January 2017

Volume

5

Issue

1

Start / End Page

67 / 70

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Quality Control
  • Humans
  • Heart Failure
  • Drug Approval
  • Cardiovascular Agents
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stockbridge, N., Miller, K., Amur, S., Hillebrenner, M., Zuckerman, B., Fiuzat, M., & Califf, R. M. (2017). The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Cardiovascular Drug Development. Jacc Heart Fail, 5(1), 67–70. https://doi.org/10.1016/j.jchf.2016.10.009
Stockbridge, Norman, Kristen Miller, Shashi Amur, Matthew Hillebrenner, Bram Zuckerman, Mona Fiuzat, and Robert M. Califf. “The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Cardiovascular Drug Development.Jacc Heart Fail 5, no. 1 (January 2017): 67–70. https://doi.org/10.1016/j.jchf.2016.10.009.
Stockbridge N, Miller K, Amur S, Hillebrenner M, Zuckerman B, Fiuzat M, et al. The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Cardiovascular Drug Development. Jacc Heart Fail. 2017 Jan;5(1):67–70.
Stockbridge, Norman, et al. “The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Cardiovascular Drug Development.Jacc Heart Fail, vol. 5, no. 1, Jan. 2017, pp. 67–70. Pubmed, doi:10.1016/j.jchf.2016.10.009.
Stockbridge N, Miller K, Amur S, Hillebrenner M, Zuckerman B, Fiuzat M, Califf RM. The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Cardiovascular Drug Development. Jacc Heart Fail. 2017 Jan;5(1):67–70.
Journal cover image

Published In

Jacc Heart Fail

DOI

EISSN

2213-1787

Publication Date

January 2017

Volume

5

Issue

1

Start / End Page

67 / 70

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Quality Control
  • Humans
  • Heart Failure
  • Drug Approval
  • Cardiovascular Agents
  • 1102 Cardiorespiratory Medicine and Haematology